Joseph Falke
Concepts (378)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chemotaxis | 43 | 2018 | 130 | 6.860 |
Why?
| Membrane Proteins | 45 | 2018 | 1105 | 5.320 |
Why?
| Bacterial Proteins | 40 | 2015 | 823 | 4.410 |
Why?
| Receptors, Amino Acid | 23 | 2009 | 25 | 3.770 |
Why?
| Signal Transduction | 42 | 2024 | 4826 | 3.620 |
Why?
| ras Proteins | 5 | 2024 | 145 | 3.520 |
Why?
| Protein Kinase C-alpha | 11 | 2023 | 37 | 3.220 |
Why?
| Protein Kinases | 18 | 2014 | 309 | 3.000 |
Why?
| Lipid Bilayers | 15 | 2023 | 97 | 2.890 |
Why?
| Cell Membrane | 24 | 2021 | 720 | 2.780 |
Why?
| Disulfides | 21 | 2014 | 96 | 2.690 |
Why?
| Calcium | 26 | 2018 | 1178 | 2.590 |
Why?
| Escherichia coli Proteins | 23 | 2015 | 177 | 2.520 |
Why?
| Phosphatidylinositol 3-Kinases | 5 | 2022 | 357 | 2.200 |
Why?
| Protein Structure, Tertiary | 33 | 2015 | 835 | 1.920 |
Why?
| Escherichia coli | 33 | 2015 | 765 | 1.750 |
Why?
| Salmonella typhimurium | 20 | 2014 | 176 | 1.750 |
Why?
| Phosphatidylinositol Phosphates | 6 | 2017 | 39 | 1.720 |
Why?
| Mutagenesis, Site-Directed | 27 | 2014 | 358 | 1.690 |
Why?
| Calcium-Binding Proteins | 17 | 2003 | 210 | 1.680 |
Why?
| Models, Molecular | 43 | 2017 | 1480 | 1.650 |
Why?
| Cysteine | 20 | 2009 | 186 | 1.650 |
Why?
| Aspartic Acid | 16 | 2009 | 79 | 1.630 |
Why?
| Protein Conformation | 35 | 2016 | 852 | 1.620 |
Why?
| Receptors, Cytoplasmic and Nuclear | 8 | 2013 | 215 | 1.550 |
Why?
| Phospholipases A | 12 | 2007 | 99 | 1.490 |
Why?
| Methyl-Accepting Chemotaxis Proteins | 24 | 2015 | 25 | 1.400 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 7 | 2016 | 29 | 1.260 |
Why?
| Histidine Kinase | 19 | 2015 | 33 | 1.210 |
Why?
| Protein Kinase C | 6 | 2018 | 253 | 1.160 |
Why?
| Protein Binding | 26 | 2023 | 2103 | 1.150 |
Why?
| Monosaccharide Transport Proteins | 10 | 1997 | 49 | 1.140 |
Why?
| Periplasmic Binding Proteins | 9 | 1997 | 13 | 1.140 |
Why?
| Guanosine Triphosphate | 3 | 2022 | 92 | 1.100 |
Why?
| Kinetics | 34 | 2014 | 1615 | 1.100 |
Why?
| Binding Sites | 29 | 2013 | 1236 | 1.060 |
Why?
| Protein Structure, Secondary | 16 | 2013 | 338 | 1.050 |
Why?
| Macrophages | 5 | 2020 | 1460 | 0.960 |
Why?
| Guanosine Diphosphate | 2 | 2021 | 20 | 0.910 |
Why?
| Electron Spin Resonance Spectroscopy | 8 | 2012 | 90 | 0.900 |
Why?
| Multiprotein Complexes | 3 | 2014 | 147 | 0.900 |
Why?
| Receptors, Cell Surface | 13 | 2007 | 371 | 0.890 |
Why?
| Calcium Signaling | 5 | 2014 | 233 | 0.880 |
Why?
| Calmodulin | 4 | 2016 | 75 | 0.870 |
Why?
| Myristoylated Alanine-Rich C Kinase Substrate | 3 | 2018 | 6 | 0.870 |
Why?
| Protein Interaction Mapping | 4 | 2010 | 107 | 0.860 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2016 | 431 | 0.850 |
Why?
| Phosphatidylinositols | 3 | 2022 | 57 | 0.810 |
Why?
| Chemoreceptor Cells | 7 | 2007 | 53 | 0.800 |
Why?
| Guanine Nucleotides | 1 | 2021 | 15 | 0.760 |
Why?
| Recombinant Proteins | 13 | 2021 | 1281 | 0.760 |
Why?
| Models, Chemical | 10 | 2013 | 263 | 0.760 |
Why?
| Cytosol | 7 | 2007 | 214 | 0.730 |
Why?
| Protein Engineering | 19 | 2013 | 105 | 0.720 |
Why?
| Class III Phosphatidylinositol 3-Kinases | 1 | 2020 | 2 | 0.720 |
Why?
| rab5 GTP-Binding Proteins | 1 | 2020 | 6 | 0.720 |
Why?
| Pseudopodia | 1 | 2020 | 22 | 0.680 |
Why?
| Phosphatidylserines | 6 | 2014 | 88 | 0.670 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2021 | 475 | 0.660 |
Why?
| Endosomes | 1 | 2020 | 126 | 0.650 |
Why?
| Spin Labels | 5 | 2008 | 46 | 0.640 |
Why?
| Amino Acid Substitution | 11 | 2014 | 281 | 0.590 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 421 | 0.580 |
Why?
| Receptors, Platelet-Derived Growth Factor | 1 | 2017 | 14 | 0.580 |
Why?
| Conserved Sequence | 3 | 2007 | 227 | 0.560 |
Why?
| Cytoplasm | 6 | 2005 | 257 | 0.560 |
Why?
| Enzyme Activation | 9 | 2017 | 799 | 0.560 |
Why?
| Phosphatidylinositol 3-Kinase | 1 | 2016 | 26 | 0.540 |
Why?
| Carrier Proteins | 9 | 1997 | 732 | 0.530 |
Why?
| Biochemistry | 2 | 2007 | 38 | 0.530 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2014 | 391 | 0.520 |
Why?
| Dimerization | 8 | 2013 | 188 | 0.520 |
Why?
| Protein Interaction Domains and Motifs | 3 | 2014 | 137 | 0.510 |
Why?
| Fluorescence Resonance Energy Transfer | 4 | 2013 | 177 | 0.510 |
Why?
| Anion Exchange Protein 1, Erythrocyte | 8 | 1986 | 22 | 0.500 |
Why?
| Protein Stability | 2 | 2014 | 160 | 0.500 |
Why?
| Biophysics | 4 | 2024 | 69 | 0.500 |
Why?
| Mutation | 11 | 2021 | 3689 | 0.490 |
Why?
| Microscopy, Fluorescence | 6 | 2017 | 399 | 0.470 |
Why?
| Magnetic Resonance Spectroscopy | 18 | 1996 | 508 | 0.470 |
Why?
| Cystine | 1 | 2014 | 17 | 0.470 |
Why?
| Spectrometry, Fluorescence | 9 | 2010 | 170 | 0.460 |
Why?
| Eukaryotic Cells | 1 | 2014 | 34 | 0.440 |
Why?
| Cell Movement | 3 | 2020 | 936 | 0.440 |
Why?
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2013 | 1 | 0.430 |
Why?
| Chlorides | 9 | 1986 | 138 | 0.430 |
Why?
| Amino Acid Sequence | 12 | 2016 | 2040 | 0.430 |
Why?
| Galactose | 8 | 1997 | 27 | 0.410 |
Why?
| Lipid Metabolism | 2 | 2007 | 491 | 0.400 |
Why?
| Adaptation, Physiological | 4 | 2020 | 514 | 0.390 |
Why?
| Thermotoga maritima | 2 | 2013 | 11 | 0.390 |
Why?
| Endosomal Sorting Complexes Required for Transport | 1 | 2012 | 35 | 0.380 |
Why?
| Diffusion | 3 | 2023 | 118 | 0.380 |
Why?
| Membrane Lipids | 2 | 2010 | 90 | 0.380 |
Why?
| Point Mutation | 3 | 2009 | 223 | 0.360 |
Why?
| Vesicular Transport Proteins | 1 | 2012 | 84 | 0.360 |
Why?
| Amino Acid Motifs | 2 | 2009 | 209 | 0.360 |
Why?
| Phosphorylation | 7 | 2021 | 1681 | 0.350 |
Why?
| Models, Theoretical | 3 | 2005 | 542 | 0.350 |
Why?
| Protein Structure, Quaternary | 2 | 2013 | 122 | 0.340 |
Why?
| RAW 264.7 Cells | 2 | 2020 | 49 | 0.320 |
Why?
| Bacterial Physiological Phenomena | 3 | 2007 | 58 | 0.310 |
Why?
| Animals | 19 | 2024 | 34479 | 0.310 |
Why?
| Peptide Fragments | 5 | 2016 | 684 | 0.300 |
Why?
| Isoenzymes | 3 | 2008 | 304 | 0.300 |
Why?
| Bacteria | 3 | 2014 | 808 | 0.300 |
Why?
| Oncogenes | 1 | 2008 | 109 | 0.300 |
Why?
| Static Electricity | 6 | 2013 | 117 | 0.290 |
Why?
| Tryptophan | 5 | 2014 | 169 | 0.280 |
Why?
| Humans | 36 | 2024 | 128417 | 0.280 |
Why?
| Membrane Microdomains | 2 | 2003 | 31 | 0.260 |
Why?
| Glycine | 2 | 2005 | 164 | 0.260 |
Why?
| Protein Domains | 2 | 2017 | 252 | 0.250 |
Why?
| Cell Line | 5 | 2018 | 2731 | 0.250 |
Why?
| Edetic Acid | 2 | 2003 | 46 | 0.230 |
Why?
| Single Molecule Imaging | 1 | 2024 | 35 | 0.230 |
Why?
| Cell Polarity | 2 | 2020 | 140 | 0.220 |
Why?
| Hot Temperature | 4 | 2021 | 358 | 0.220 |
Why?
| Protein Kinase C beta | 3 | 2014 | 21 | 0.210 |
Why?
| Cations, Divalent | 4 | 2010 | 54 | 0.210 |
Why?
| Spin Trapping | 1 | 2003 | 3 | 0.210 |
Why?
| Water | 3 | 2004 | 440 | 0.210 |
Why?
| Recombinant Fusion Proteins | 4 | 2010 | 634 | 0.210 |
Why?
| Peptides | 2 | 2000 | 908 | 0.210 |
Why?
| Mice | 8 | 2020 | 16602 | 0.210 |
Why?
| Surface Properties | 5 | 2004 | 393 | 0.200 |
Why?
| Plasmids | 5 | 2007 | 354 | 0.200 |
Why?
| Electrophoresis, Polyacrylamide Gel | 4 | 2009 | 323 | 0.200 |
Why?
| Molecular Dynamics Simulation | 4 | 2014 | 217 | 0.200 |
Why?
| Phosphatidylcholines | 5 | 2007 | 146 | 0.200 |
Why?
| Cyclophilin A | 1 | 2002 | 26 | 0.190 |
Why?
| Phosphotransferases | 1 | 2001 | 24 | 0.190 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2004 | 203 | 0.190 |
Why?
| Chemotactic Factors | 2 | 2007 | 54 | 0.180 |
Why?
| Hydrolysis | 1 | 2021 | 184 | 0.180 |
Why?
| Fluorescent Dyes | 4 | 2007 | 311 | 0.180 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2021 | 80 | 0.180 |
Why?
| Reproducibility of Results | 3 | 2021 | 3020 | 0.180 |
Why?
| Aspartate Kinase | 1 | 2000 | 1 | 0.180 |
Why?
| Metals | 3 | 1997 | 127 | 0.180 |
Why?
| Molecular Sequence Data | 6 | 2005 | 2819 | 0.180 |
Why?
| Intracellular Membranes | 1 | 2020 | 82 | 0.170 |
Why?
| Diclofenac | 1 | 2020 | 14 | 0.170 |
Why?
| Glutamic Acid | 3 | 2011 | 230 | 0.170 |
Why?
| Time-Lapse Imaging | 1 | 2020 | 19 | 0.170 |
Why?
| Chelating Agents | 2 | 1997 | 66 | 0.170 |
Why?
| Lymphocyte Antigen 96 | 2 | 2010 | 24 | 0.170 |
Why?
| Ibuprofen | 1 | 2020 | 80 | 0.170 |
Why?
| Endocytosis | 1 | 2020 | 161 | 0.160 |
Why?
| Alanine | 2 | 2013 | 141 | 0.160 |
Why?
| Troponin C | 1 | 1998 | 5 | 0.160 |
Why?
| Oxidation-Reduction | 3 | 2010 | 1001 | 0.150 |
Why?
| Ultraviolet Rays | 1 | 2021 | 384 | 0.150 |
Why?
| Membranes, Artificial | 1 | 1998 | 69 | 0.150 |
Why?
| Thermodynamics | 6 | 2002 | 405 | 0.150 |
Why?
| Crystallography, X-Ray | 3 | 2013 | 433 | 0.150 |
Why?
| Phospholipases A2 | 5 | 2006 | 79 | 0.150 |
Why?
| Phosphopeptides | 1 | 2017 | 17 | 0.150 |
Why?
| Synaptotagmins | 2 | 2012 | 20 | 0.150 |
Why?
| Acetaminophen | 1 | 2020 | 243 | 0.140 |
Why?
| Solvents | 4 | 1999 | 107 | 0.140 |
Why?
| Terbium | 2 | 1996 | 4 | 0.140 |
Why?
| Biophysical Phenomena | 3 | 2010 | 64 | 0.140 |
Why?
| Sf9 Cells | 1 | 2016 | 9 | 0.140 |
Why?
| Aspirin | 1 | 2020 | 376 | 0.140 |
Why?
| Spodoptera | 1 | 2016 | 37 | 0.140 |
Why?
| Magnesium | 3 | 1998 | 150 | 0.130 |
Why?
| Leukocytes | 1 | 2018 | 303 | 0.130 |
Why?
| Structure-Activity Relationship | 6 | 2013 | 530 | 0.130 |
Why?
| Ligands | 5 | 2010 | 614 | 0.130 |
Why?
| Fluorine Radioisotopes | 1 | 1996 | 11 | 0.130 |
Why?
| Cloning, Molecular | 5 | 1997 | 522 | 0.130 |
Why?
| Cattle | 2 | 2008 | 960 | 0.130 |
Why?
| Erythrocyte Membrane | 8 | 1986 | 49 | 0.120 |
Why?
| Group IV Phospholipases A2 | 3 | 2006 | 45 | 0.120 |
Why?
| Fluorine | 5 | 1993 | 15 | 0.120 |
Why?
| Macromolecular Substances | 3 | 2010 | 211 | 0.120 |
Why?
| Osmolar Concentration | 3 | 2009 | 164 | 0.120 |
Why?
| Glutathione Transferase | 2 | 2007 | 99 | 0.120 |
Why?
| Substrate Specificity | 3 | 2008 | 365 | 0.120 |
Why?
| Protein Transport | 2 | 2007 | 420 | 0.120 |
Why?
| Hydrophobic and Hydrophilic Interactions | 2 | 2012 | 184 | 0.120 |
Why?
| Protein Isoforms | 2 | 2013 | 378 | 0.120 |
Why?
| Microarray Analysis | 1 | 2014 | 120 | 0.110 |
Why?
| Bacteriorhodopsins | 2 | 2005 | 11 | 0.110 |
Why?
| Phospholipids | 2 | 2013 | 207 | 0.110 |
Why?
| Hydrogen-Ion Concentration | 4 | 2009 | 536 | 0.110 |
Why?
| Immunity, Innate | 1 | 2020 | 802 | 0.110 |
Why?
| Models, Biological | 6 | 2007 | 1691 | 0.110 |
Why?
| Neoplasms | 1 | 2008 | 2464 | 0.110 |
Why?
| Biological Transport, Active | 7 | 1986 | 72 | 0.110 |
Why?
| Protein Folding | 3 | 2002 | 265 | 0.110 |
Why?
| Proteolysis | 1 | 2014 | 162 | 0.110 |
Why?
| Histidine | 2 | 2007 | 58 | 0.110 |
Why?
| Protein Denaturation | 3 | 2002 | 74 | 0.110 |
Why?
| Phospholipases A2, Cytosolic | 1 | 2013 | 6 | 0.110 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2007 | 251 | 0.110 |
Why?
| Myocardium | 1 | 1998 | 965 | 0.110 |
Why?
| Protein Multimerization | 1 | 2014 | 178 | 0.110 |
Why?
| Fibroblasts | 1 | 2018 | 935 | 0.100 |
Why?
| Molecular Docking Simulation | 1 | 2013 | 109 | 0.100 |
Why?
| Mutagenesis | 1 | 2013 | 181 | 0.100 |
Why?
| Trypsin | 1 | 2012 | 74 | 0.100 |
Why?
| Synaptotagmin I | 1 | 2012 | 13 | 0.100 |
Why?
| Multienzyme Complexes | 1 | 2012 | 68 | 0.100 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2012 | 58 | 0.100 |
Why?
| Molecular Structure | 4 | 1996 | 464 | 0.100 |
Why?
| Computer Simulation | 5 | 2013 | 939 | 0.100 |
Why?
| Myosin-Light-Chain Kinase | 1 | 2012 | 20 | 0.100 |
Why?
| Transfection | 2 | 2011 | 893 | 0.100 |
Why?
| NIH 3T3 Cells | 1 | 2011 | 141 | 0.090 |
Why?
| Energy Transfer | 2 | 2002 | 51 | 0.090 |
Why?
| Time Factors | 2 | 2016 | 6482 | 0.090 |
Why?
| Fluoresceins | 2 | 2003 | 47 | 0.090 |
Why?
| Carbohydrate Metabolism | 1 | 1991 | 60 | 0.090 |
Why?
| In Vitro Techniques | 3 | 2003 | 1039 | 0.090 |
Why?
| Facilitated Diffusion | 1 | 2010 | 3 | 0.090 |
Why?
| Hydrodynamics | 1 | 2010 | 40 | 0.090 |
Why?
| Toll-Like Receptor 4 | 2 | 2010 | 262 | 0.090 |
Why?
| Niflumic Acid | 2 | 1986 | 3 | 0.090 |
Why?
| Sequence Homology, Amino Acid | 2 | 2004 | 367 | 0.080 |
Why?
| Heterocyclic Compounds, 3-Ring | 1 | 2010 | 31 | 0.080 |
Why?
| Toll-Like Receptors | 1 | 2010 | 179 | 0.080 |
Why?
| Crystallization | 2 | 2013 | 137 | 0.080 |
Why?
| Single-Cell Analysis | 1 | 2011 | 272 | 0.080 |
Why?
| Photobleaching | 1 | 2009 | 22 | 0.080 |
Why?
| Methyltransferases | 1 | 2009 | 69 | 0.080 |
Why?
| Least-Squares Analysis | 1 | 2009 | 72 | 0.080 |
Why?
| 3T3 Cells | 1 | 2008 | 151 | 0.080 |
Why?
| Cations | 2 | 2002 | 79 | 0.080 |
Why?
| Hydrogen Bonding | 2 | 2014 | 149 | 0.070 |
Why?
| Blood Proteins | 2 | 2013 | 239 | 0.070 |
Why?
| Ethylmaleimide | 2 | 2003 | 18 | 0.070 |
Why?
| Phosphoproteins | 2 | 2013 | 327 | 0.070 |
Why?
| Sensory Receptor Cells | 1 | 1988 | 93 | 0.070 |
Why?
| Receptors, Neurotransmitter | 1 | 1987 | 16 | 0.070 |
Why?
| Archaeal Proteins | 1 | 2007 | 48 | 0.070 |
Why?
| Cell Survival | 2 | 2008 | 1077 | 0.070 |
Why?
| Nicotinic Acids | 1 | 1986 | 6 | 0.070 |
Why?
| Oligonucleotide Probes | 1 | 2007 | 50 | 0.070 |
Why?
| Benzenesulfonates | 1 | 1986 | 18 | 0.070 |
Why?
| Feedback | 1 | 2007 | 159 | 0.070 |
Why?
| Oxadiazoles | 1 | 1986 | 33 | 0.070 |
Why?
| Taurine | 1 | 1986 | 40 | 0.070 |
Why?
| Lysine | 1 | 2008 | 278 | 0.070 |
Why?
| Calcium Channel Blockers | 1 | 1986 | 123 | 0.060 |
Why?
| Methylation | 2 | 1997 | 227 | 0.060 |
Why?
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1985 | 12 | 0.060 |
Why?
| Structural Homology, Protein | 1 | 2005 | 25 | 0.060 |
Why?
| Swine | 1 | 2008 | 742 | 0.060 |
Why?
| Drug Delivery Systems | 1 | 2008 | 325 | 0.060 |
Why?
| Actins | 1 | 2007 | 401 | 0.060 |
Why?
| Organometallic Compounds | 2 | 2000 | 105 | 0.060 |
Why?
| Motion | 2 | 1996 | 98 | 0.060 |
Why?
| Sequence Homology | 1 | 2004 | 40 | 0.060 |
Why?
| Analgesics, Opioid | 2 | 2010 | 887 | 0.060 |
Why?
| Phosphatidylethanolamines | 2 | 2002 | 74 | 0.060 |
Why?
| Dogs | 1 | 2005 | 366 | 0.060 |
Why?
| Mathematics | 4 | 1985 | 103 | 0.060 |
Why?
| Halobacterium | 1 | 1984 | 3 | 0.060 |
Why?
| Membrane Potentials | 1 | 2005 | 260 | 0.060 |
Why?
| Periplasm | 1 | 2004 | 11 | 0.060 |
Why?
| Rhodopsin | 1 | 2004 | 10 | 0.060 |
Why?
| Carotenoids | 1 | 1984 | 38 | 0.060 |
Why?
| Liposomes | 2 | 2012 | 168 | 0.060 |
Why?
| Lipopolysaccharides | 1 | 2007 | 856 | 0.060 |
Why?
| Computer Graphics | 2 | 1996 | 41 | 0.050 |
Why?
| Rhodamines | 1 | 2003 | 17 | 0.050 |
Why?
| Cyclic N-Oxides | 1 | 2003 | 30 | 0.050 |
Why?
| Data Interpretation, Statistical | 1 | 2004 | 335 | 0.050 |
Why?
| Fluorescein | 1 | 2003 | 25 | 0.050 |
Why?
| Peptide Library | 1 | 2003 | 83 | 0.050 |
Why?
| Urea | 1 | 2002 | 75 | 0.050 |
Why?
| Glucose | 3 | 1992 | 982 | 0.050 |
Why?
| Peptide Hydrolases | 1 | 2003 | 105 | 0.050 |
Why?
| Dansyl Compounds | 1 | 2002 | 5 | 0.050 |
Why?
| Sulfhydryl Compounds | 2 | 1998 | 185 | 0.050 |
Why?
| Catalysis | 1 | 2002 | 305 | 0.040 |
Why?
| Lipids | 1 | 2005 | 620 | 0.040 |
Why?
| Proteins | 1 | 2007 | 932 | 0.040 |
Why?
| Nitrogen | 1 | 2002 | 165 | 0.040 |
Why?
| Chlorine | 3 | 1985 | 58 | 0.040 |
Why?
| Stilbenes | 3 | 1985 | 36 | 0.040 |
Why?
| Arginine | 1 | 2002 | 258 | 0.040 |
Why?
| Nitrilotriacetic Acid | 1 | 2000 | 1 | 0.040 |
Why?
| Benzoxazoles | 1 | 1980 | 19 | 0.040 |
Why?
| Chromatography, Affinity | 1 | 2000 | 83 | 0.040 |
Why?
| Indicators and Reagents | 1 | 2000 | 105 | 0.040 |
Why?
| Nickel | 1 | 2000 | 54 | 0.040 |
Why?
| Sequence Alignment | 2 | 1998 | 329 | 0.040 |
Why?
| Staining and Labeling | 1 | 1980 | 137 | 0.040 |
Why?
| Iodides | 1 | 1998 | 6 | 0.040 |
Why?
| Pyrimidinones | 1 | 1980 | 101 | 0.040 |
Why?
| Naphthalenesulfonates | 1 | 1998 | 7 | 0.040 |
Why?
| Fluorescence Polarization | 1 | 1998 | 38 | 0.040 |
Why?
| Isotopes | 2 | 1991 | 28 | 0.040 |
Why?
| Muscles | 1 | 1980 | 322 | 0.040 |
Why?
| Membrane Glycoproteins | 1 | 2001 | 466 | 0.040 |
Why?
| Chickens | 1 | 1998 | 187 | 0.040 |
Why?
| Pain Measurement | 2 | 2010 | 487 | 0.030 |
Why?
| Nerve Tissue Proteins | 1 | 2001 | 567 | 0.030 |
Why?
| Sequence Analysis | 1 | 1996 | 37 | 0.030 |
Why?
| Solubility | 1 | 1997 | 229 | 0.030 |
Why?
| Strontium | 2 | 1998 | 14 | 0.030 |
Why?
| Chemistry, Physical | 1 | 1996 | 37 | 0.030 |
Why?
| Chemical Phenomena | 1 | 1996 | 80 | 0.030 |
Why?
| Models, Structural | 1 | 1995 | 40 | 0.030 |
Why?
| Tetrahydrofolate Dehydrogenase | 1 | 1996 | 22 | 0.030 |
Why?
| L-Lactate Dehydrogenase | 1 | 1996 | 116 | 0.030 |
Why?
| Genetic Engineering | 1 | 1996 | 88 | 0.030 |
Why?
| Flagella | 1 | 1995 | 19 | 0.030 |
Why?
| Anions | 2 | 1985 | 30 | 0.030 |
Why?
| Genes, Bacterial | 1 | 1995 | 158 | 0.030 |
Why?
| p-Fluorophenylalanine | 1 | 1994 | 2 | 0.030 |
Why?
| Glutamates | 1 | 1994 | 56 | 0.030 |
Why?
| Electrons | 1 | 2014 | 78 | 0.030 |
Why?
| Cations, Monovalent | 1 | 1993 | 6 | 0.030 |
Why?
| Carboxylic Acids | 1 | 1993 | 32 | 0.030 |
Why?
| Movement | 1 | 1995 | 269 | 0.030 |
Why?
| Cryoelectron Microscopy | 1 | 2014 | 177 | 0.030 |
Why?
| Iodoacetamide | 1 | 1992 | 5 | 0.030 |
Why?
| Trehalose | 1 | 2012 | 30 | 0.030 |
Why?
| Organophosphates | 1 | 1993 | 120 | 0.020 |
Why?
| Rats | 2 | 2010 | 5165 | 0.020 |
Why?
| Gadolinium | 1 | 1991 | 77 | 0.020 |
Why?
| Molecular Conformation | 1 | 1991 | 139 | 0.020 |
Why?
| Lac Operon | 1 | 1990 | 45 | 0.020 |
Why?
| Infusion Pumps | 1 | 2009 | 31 | 0.020 |
Why?
| Toll-Like Receptor 2 | 1 | 2010 | 110 | 0.020 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2010 | 95 | 0.020 |
Why?
| Injections, Spinal | 1 | 2009 | 106 | 0.020 |
Why?
| Receptors, Opioid, mu | 1 | 2009 | 56 | 0.020 |
Why?
| Morphine | 1 | 2010 | 126 | 0.020 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 1991 | 322 | 0.020 |
Why?
| Hyperalgesia | 1 | 2009 | 108 | 0.020 |
Why?
| Analgesia | 1 | 2009 | 92 | 0.020 |
Why?
| Naloxone | 1 | 2009 | 110 | 0.020 |
Why?
| Microglia | 1 | 2010 | 228 | 0.020 |
Why?
| Narcotic Antagonists | 1 | 2009 | 160 | 0.020 |
Why?
| Reaction Time | 1 | 2009 | 408 | 0.020 |
Why?
| Allosteric Regulation | 1 | 1987 | 99 | 0.020 |
Why?
| Species Specificity | 1 | 1988 | 568 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2010 | 1228 | 0.020 |
Why?
| Substance Withdrawal Syndrome | 1 | 2009 | 169 | 0.020 |
Why?
| Dinitrofluorobenzene | 1 | 1986 | 7 | 0.020 |
Why?
| Cyclohexanones | 1 | 1986 | 9 | 0.020 |
Why?
| Dipyridamole | 1 | 1986 | 25 | 0.020 |
Why?
| Cell Fractionation | 1 | 1986 | 56 | 0.020 |
Why?
| Phenylglyoxal | 1 | 1985 | 1 | 0.020 |
Why?
| Papain | 1 | 1985 | 4 | 0.020 |
Why?
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1985 | 8 | 0.020 |
Why?
| Interleukin-1 | 1 | 2010 | 961 | 0.020 |
Why?
| Chymotrypsin | 1 | 1985 | 19 | 0.020 |
Why?
| Bromine | 1 | 1985 | 6 | 0.020 |
Why?
| Sonication | 1 | 1985 | 13 | 0.020 |
Why?
| Bicarbonates | 1 | 1985 | 42 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 1990 | 1198 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2010 | 1185 | 0.010 |
Why?
| Biological Transport | 1 | 1985 | 394 | 0.010 |
Why?
| Cytoskeleton | 1 | 1985 | 180 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 1994 | 1628 | 0.010 |
Why?
| Halorhodopsins | 1 | 1984 | 1 | 0.010 |
Why?
| Bromides | 1 | 1984 | 5 | 0.010 |
Why?
| Cold Temperature | 1 | 1985 | 153 | 0.010 |
Why?
| Radioisotopes | 1 | 1984 | 31 | 0.010 |
Why?
| Binding, Competitive | 1 | 1984 | 199 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2009 | 2239 | 0.010 |
Why?
| Mice, Knockout | 1 | 2010 | 2755 | 0.010 |
Why?
| Cells, Cultured | 1 | 2010 | 4001 | 0.010 |
Why?
| Chick Embryo | 1 | 1980 | 130 | 0.010 |
Why?
| Cell Membrane Permeability | 1 | 1980 | 80 | 0.010 |
Why?
| Barium | 1 | 1998 | 27 | 0.010 |
Why?
| CHO Cells | 1 | 1998 | 150 | 0.010 |
Why?
| COS Cells | 1 | 1998 | 184 | 0.010 |
Why?
| Cricetinae | 1 | 1998 | 275 | 0.010 |
Why?
| Blood Glucose | 1 | 1986 | 2093 | 0.010 |
Why?
| Male | 2 | 2010 | 62857 | 0.010 |
Why?
| Cytochalasin B | 1 | 1986 | 17 | 0.000 |
Why?
|
|
Falke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|